Neurocrine Bio. (NBIX) PT Raised to $90 at Cowen as Ingrezza Blows Past Expectations
Tweet Send to a Friend
Cowen analyst Phil Nadeau raised his price target on Neurocrine Bio. (NASDAQ: NBIX) to $90.00 (from $65.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
